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Abstract: Patient Information Leaflets accompanying medicine are heavily regulated
by European and individual national legislation in the way they need to be designed,
written, and produced. Further, the design of these leaflets is still firmly anchored in
a printed document-based paradigm. This means that transposing them for use by
mobile devices, such as smart phones or tablets is a process that is not well
understood. This paper shows how Information Designers can offer insights to a
problem that will become increasingly prevalent, as the demands on the ‘message’
surpass the medium of the paper-based document and seek to harvest the potential
of mobile devices to offer hypertext, multimedia and tailored information. This paper
investigates the problem via a case study examining pain relieving (Fentanyl)
transdermal patches and offers some lessons learnt from this experience, in order to
open up and shed light on this emerging aspect of information design practice.
Keywords: Information Design, Patient Information Leaflets, Mobile devices

Preamble
Fentanyl is one of a small number of drugs that may be especially harmful, and in some
cases fatal, with just one dose, if used incorrectly. It is used for the management of chronic
and intractable pain. For home use, patients are prescribed the drug in the form of
transdermal patches, that is, adhesive patches that are stuck on the skin, so the drug is
absorbed in this way. In 2010, the UK’s Medicines and Healthcare Products Regulatory
Agency (MHRA), showcased the manufacturers’ Patient Information Leaflet as an example of
‘best practice’ (MHRA, 2010). Yet, only a few years after, the same agency issued a safety
warning via the UK government offices (MHRA 2014) noting that there had already been
three reports of serious incidents, two of them involving children, and strongly urged
advising patients and carers to follow the instructions on the carton and in the
This work is licensed under a Creative Commons Attribution-Non Commercial 4.0
International License.
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accompanying leaflet. Given this state of affairs, the questions must be asked about how
effective is the leaflet; about what should we be doing to increase its effectiveness, and
more generally, to increase the health literacy of patients and carers.

Introduction
Patient Information Leaflets (PILs) refer specifically to the printed paper-based information
that accompanies medicinal products. These leaflets are found in the carton that contains
the medicine. The instructions for the patients should leave no margin for error, since
correct usage can be extremely critical. Patients who do not take their medicine correctly
may not respond to therapy and get no relief from symptoms, but they may also place
themselves at great risk.
Due to the critical nature of the information contained in the leaflets, the information design
and presentation are heavily regulated by bodies, such as the MHRA, the European
Medicines Agency (EMA) and the Federal Drug and Food Agency (FDA) in the USA. There is a
recommended format of headings and order in which the information is presented. These
measures are laid down, in order to ensure “clarity, consistency and accuracy of the
medicinal product information.” It is mandatory for PILs to accompany every medicine
package: the authoring of PILs is the responsibility of the manufacturer, while the leaflets for
new medicines must undergo readability tests for a licence to be granted. Typically, in
readability tests, testers are asked to read the leaflets and perform certain tasks, e.g. find
the correct dosage for a certain patient. Pictograms (Katz et al, 2006) are also subject to the
some readability criteria. The criteria are metric based and require a high success rate
(between 80-90%) on the tasks’ accomplishment. The purpose of these tests is to
demonstrate that the leaflet is
“..written and designed to be clear and understandable, enabling the users to act
appropriately, when necessary with the help of health professionals.” (European
Commission, 2001 and 2009)

This level of regulation is a considerable achievement and represents over three decades of
work from various actors including: consumer organisations; regulatory bodies;
pharmaceutical companies; marketing and communication experts; academic pharmacists
and information designers. It is a continuous process including considerations, such as
include information in braille on the packaging (European Commission, 2005).
However, regulatory frameworks can only offer a basis on which to work, and information
designers can offer input into creating more attractive and usable layouts and writing styles
(Waarde, 1998; Bohm, 2014; Dickinson et al. 2010). The limits of regulatory frameworks,
especially where compliance with regulations is mandated, can be seen in other cases,
notably web accessibility, where following the guidelines does not automatically guarantee a
good user experience (Petrie & Bevan, 2009). Nor should regulatory frameworks be
expected to cope with every contingency, and while readability tests may be carried out,
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users in real life situations may need more support to find crucial information at the
moment they need it.
In addition, advances in the ways that drugs are dispensed, such as nasal sprays and
transdermal patches, and even wearable insulin pumps mean that knowledge and training
(Gani et al. 2001) is critically needed by patients and carers to help them understand how to
handle these new pathways and avoid dangers. Although the guidelines of PILs can be
adapted, a regulatory framework cannot be expected to cope with every instance. Some
manufacturers collect frequently asked questions (FAQs) and include answers to them in the
leaflet, thus adding this information at the end of the mandated format. This is actually a
feature of the version of PIL for fentanyl patches in the USA. When a drug is particularly
problematic, the regulation agency may take extra measures to inform the public. In the
case of Fentanyl patches, the FDA has released information in a number of formats, such as
warnings and advisories including two videos, because it
“has continued to receive reports of deaths and life-threatening side effects in patients
who use the fentanyl patch […] the reports indicate that patients are continuing to
incorrectly use the fentanyl patch..." (FDA 2013)

Drug companies routinely publish the leaflet online in portable document format (.pdf), so
that it retains all the characteristics of information presentation as the paper-based
documents. In this way the online version is consistent with the paper version. But the .pdf
of a document is linear, and may not transform gracefully to a small screen of a mobile
phone. Anecdotally, many people in our survey report needing to use the official patient
information online, because the paper leaflet gets lost or damaged, while others simply
expressed a preference to access information online. A recent study (Hammerschmidt &
Spinillo, 2014) tested the use of mobile devices to access the .pdf of the patient leaflet.
Interestingly the test participants, although they performed more poorly using the .pdf on
tablet devices than with the paper-based .pdf, firmly believed that the mobile devices would
be their preferred way of interacting and obtaining such information. They also expressed
the opinion that this would be the preference of other people as well.
Modern digital technologies now offer us new ways to access information, but also new
means to communicate information. However, it is not always clear what and how to
present it. On the other hand, it is important to have access to mandated formats.
This paper presents the results of a case study that investigated transposing the
authoritative .pdf version of the manufacturer’s PIL for Fentanyl transdermal patches into an
interactive presentation rendered for a tablet device. The idea was that, apart from having
access to the .pdf, patients could use the new rendering to go quickly to the information
they wanted, rather than have to read through information that was not appropriate to their
situation; in addition, some information visualisation techniques and graphical elements
were tested. The purpose of the study was to answer the research question regarding the
contribution of Information Design to this situation by creating a prototype and evaluating it
with a variety of stakeholders.
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Case Study
An overview of the research undertaken, in terms of the literature review, data collection
and analysis, the creation of a prototype, and its evaluation is given. In all the activities, the
involvement of stakeholders was heavily emphasized, since this is a complex problematic
area, where there are many human centred interests and activities.

3.1 Literature review phase
The main tasks in the literature review phase were to carry out a general investigation into
patient error in medication use, which reveals the worrying extent of the problem –
between 30-50% of those prescribed medicine are not taking it correctly (Barber, 2002) and more specifically, a review of work regarding patient information, especially in terms of
PILs. This included studying the design rational behind the formats for PILS set out in various
legal frameworks with regard to the content and presentation of PILS, especially in terms of
the rendering the equivalent information online. This revealed that there are no suggestions
in the regulatory framework about how newer ways of consuming information with the use
of mobile devices, such as tablet and phones, should be handled. There is an underlying
assumption that the leaflets should be transposed to electronic formats in exactly the same
way as it was on paper. However, in the general literature there are suggestions for
pictograms (Katz et al. 2006, Mansoor & Dowse, 2004) and other visual aids (Waarde, 1998),
as well as many other studies on improving PILs (Bouayad-Agda et al., 1998, Dickinson et al.,
2001; Dickinson et al., 2010; Dickinson, 2014; Dixon-Woods, 2001; Maat & Lentz, 2010,
Harris et al, 2015). Finally, elsewhere, in computing literature, there are attempts to provide
support to health information seekers by determining the context of use, so that the
information can be better tailored to needs (Schmidtke et al., 2014).

3.2. Investigating problems with Fentanyl transdermal patches
A series of semi-structured interviews with seven healthcare professionals from a provincial
hospital located in Sparti, Greece, were undertaken, during six visits to the hospital and
related premises. In terms of their roles: three of those interviewed were doctors and four
were nursing staff, and all were involved in offering training to patients and carers regarding
the use of the patches.
It was not possible to interview patients and carers, because of ethical constraints. Instead,
research was carried out looking at the most commonly encountered problems mentioned
in online support groups of patients, users of Fentanyl, and their carers. In addition, an
online survey was carried out, with 253 respondents. Briefly, the profile of the respondents
were more women than men (64% women and 36% men), with age range from 18 to over
65. The bulk of the respondents aged between 18-34 (64%) and 35-65 and above (36%). 81%
had finished tertiary education.
The healthcare professionals were asked what they felt were the main difficulties for
patients and their carers. A sample of the most common questions they answer for patients
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(who, in their experience, either a) do not consult the leaflet; or b) do not find the
information on the leaflet; or c) do not recognise the information as applicable to their case)
are listed below:
x How do I stick it on?
x How often should I change it?
x Which parts of the body are the best to use /are there specific parts which are
better than others?
x How can I bathe, if I have a patch stuck on me?
x The plaster came off, what should I do when that happens?
x What do I do about the side effects of itchiness, diarrhoea?
x Is the sticky part the actual drug (how does it work?)?
The most common mistakes on the part of the patients and their carers as reported by the
healthcare professionals (in approximate order of frequency) were:
x
x
x
x
x

Applying the wrapper of the plaster onto the skin, instead of the plaster itself
Applying the plaster in difficult to stick places, e.g. where there is body hair
Applying the plaster without having swabbed the skin to prepare it
Forgetting to remove the old plaster before applying the new one
Applying the plaster in inappropriate places, e.g. where it will rub on clothing,
or come into contact with objects, etc.

Some of these questions and mistakes were found in the topics of concern to patients and
carers in the online support groups. Their topics of concern were analysed and categorised
into the following groupings (in order of perceived importance):
x Issues regarding the application of the plaster: Frequent reports of difficulties
for the patches to stay stuck; how to correctly apply the patch again when it
has come unstuck; exactly which parts of the body can help with the unsticking
problem
x The importance of ambient temperature: Patients record experiences of using
the patch in high temperatures and having signs of overdosing. Others noted
that wearing the patch during very long and hot baths have also caused the
same signs
x Dosage instructions: Concern over accidental death of a carer from fentanyl
overdose caused by mishandling of patches; uncertainty about how the dosage
of the patches can be lowered
x Can the dosage be lowered? People report experimenting with the dosage, by
cutting the plaster in half and sticking half a plaster, does this really work, how
dangerous is it?
x Stopping the use of Fentanyl patches: Withdrawal symptoms are common
after cessation of the use of patches, and patients and carers draw attention to
this, and emphasise the importance of gradual lessening of use.
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x Storage: Because of the opiate content of the patches, patients and carers are
concerned about the security of storage especially from substance abusers
x Interaction with other drugs or substances: Since the patches are used by
people with a wide range of health problems, of which pain and its
management is but one manifestation, patients and carers are particularly
worried about interactions with other drugs.
With regard to the correspondence of these concerns to the kind of information provided by
the manufacturer of the PIL, some information, for instance the secure storage of the
medicine, regards an issue that is beyond the remit of the PIL. However, other concerns, like
whether it was possible to halve the dose or interfere with the frequency of patch
application by cutting one dose in half, require serious responses in the PIL discouraging
tampering with the product, and clearer information about how the product ‘works’.

3.3 PILs for Fentanyl transdermal patches; the opinions of stakeholders
It is recognised that, with regard to PILs, there has to be a trade-off between the amount of
information in the PIL and how much patients really need. Comparison of PILs for the same
product and same manufacturer but conforming to different regulatory frameworks (i.e.
from Greece that conforms to the European standard, from the USA and from Australia)
revealed differences in length and in organisation. Even though the Greek one was far
shorter than its US counterpart, the healthcare professionals still felt that some parts of the
PIL were not needed for the patient. As an example, they felt that details regarding the
action of the drug were not understandable by the patient. Further they felt that people
were probably not paying much attention to the PIL and that just the length of the
document would discourage some. Results from the online survey corroborated some of
these opinions. Of the 253 replies:
x
x
x
x

59.3% replied that they always read PILs
25.9% replied that they frequently read PILs
12.4% that rarely read PILs
2.4% choose never to read PILs

To these quantitative results, the respondents added comments to the effect that they
wanted the information, even if they choose not to read it always. Those who replied that
they rarely read PILs noted that they got the information from other sources, such as verbal
advice from healthcare professionals and pharmacists. Amongst those who always read PILs,
they complained that they were not written in a way they could understand; that there was
too much information that probably was of no use to them, even if they could understand it;
and that often they did not find the information they wanted, or did not find it easily.
However, when both the professionals and patients and carers were asked to rate different
groupings of information into 3 categories of ‘very important’,’ important’ and ‘less
important’, the results show a mixed picture, with some clear agreement and some strong
disagreement. Figure 1 below shows the consolidated results of this exercise.
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Figure 1: Comparison of ratings from healthcare professionals and online survey respondents to PIL
headings.

The qualitative comments that accompanied the ratings showed that both healthcare
professionals and online survey respondents had difficulty rating the information according
to the headings. In some cases the rated importance of the heading did not correspond the
rated importance of the information under the heading, or the sequence of headings were
not meaningful to them.
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Accordingly, an iterative card sorting exercise was carried out to understand what kind of
headings and their information contents helped the stakeholders. Figure 2 below shows the
results of the card sorting; the information of the 26 cards was drawn from the 3 versions of
the fentanyl transdermal patches PILs that were studied. The main information to be gained
from this were the seven groupings of information for patients and their carers (shown in
blue at the top of each information box).

Figure 2: Final results of the card sorting.

An interesting result from these exercises was the importance non-medical professionals
gave to information that medical professionals felt was not useful for patients. Such
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information is side effects and interactions with other drugs. The health professionals in our
study felt that this information was not needed by their patients and their carers, because
each patient was under the care of a team of doctors and nurses. However, the online
survey respondents felt they wanted all the information. The doctors were of the opinion
that patients spent too much time and effort on these information units, and neglected to
pay deep attention to the important instructions for using and disposing of the plasters.

3.4 PILs in other renderings
A number of alternative ways of presenting the information, especially videos which are a
popular means of presenting such information were studied. The range here was from the
authoritative to the amateur, with some carers and patients feeling strongly enough about
the subject to create their own explanations of what to use to help fellow sufferers and their
families. A further source of instructional material was from blogs, support group
newsletters and other informal sources.
In addition, a small review of literature was carried out to discover the trends in online
health information seeking. The 253 respondents in the online survey were also asked to
state, whether they used mobile devices (smart phones and tablets) and if so, what they
used them for:
x
x
x
x

To have access to email (90%)
To have access to the Internet (78%),
To get news (76%)
To take photographs (71%)

When asked if they would like to download PILs, in case they were available, 76% of those
who used mobile devices, answered positively.
This result agrees with the finding (Hammerschmidt & Spinillo, 2014) that people are very
open to electronically based information. Of course, the fact that many people search
generally online for health information in a browsing mode should not be confused with
looking up a PIL for dosage instructions at a critical moment.

3.5 Creating a prototype of a tablet based PIL
Taking the results of the research and associated analyses, along with general guidelines for
accessibility and usability of web based information, and more recently mobile web based
information, and retaining recommendations and best practice examples results from paper
based information design regarding layout, typeface and general content design, a
conceptual model of a prototype was built. A conceptual model presents a visualisation of
the organisation and the functions of the prototype, along with basic meanings and activities
of the system, in order to communicate it to other parties. It is by no means technically
accurate, as the aim is to present a system to potential users and for them to understand
what it is for. As shown in Figure 3, the model allows for visualising screen contents,

2317

Myrto Koumoundourou, Panayiotis Koutsabasis and Jenny S. Darzentas

navigation through content and gestures for interacting with the content displayed on the
device.

Figure 3: Conceptual model of the prototype tablet device based PIL for Fentanyl Transdermal Patch

To build the prototype, Use scenarios were also created, as shown in Figure 4, to trial typical
uses of the system, as perceived from our research, as well as the information categories
derived from the card sorting exercise.

Figure 4: Part of the scenario for persona
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In terms of presentation, following the work of van der Waarde (1998), Dickinson et al
(2010), Bouayad-Agha et al. (1998) regarding the ease of use of PILS, there was an attempt
to reduce the amount of text with the use of visualisations, as well as the graphical elements
inside the text (borders, colours, typographical elements) to make the information easier to
scan, since it is acknowledged that this is the dominant reading style on the internet (Kress,
2004, Nielsen, 2007). It also makes easier to understand the relationships between blocks of
information and the degrees of importance of information. Figure 5 shows the “artists’
impression” of the tablet with the application active, while Figure 6 shows a typical screen
from the application.

Figure 5: The tablet application open showing the start of instructions for applying the patch.

Figure 6: A screenshot showing deeper levels of patch application instructions and explanations.
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3.6 Evaluating the prototype
The resulting designs were implemented on a nine inch tablet device, and underwent both
formative and summative evaluations. Formative evaluations, which allow corrections
during the design process, are used to test systems, while summative evaluations take place
after the completion of the system’s design. Five evaluators helped with the formative
evaluations: three were design students, two of whom were tablet users of more than one
year’s standing; the fourth evaluator was a student with no knowledge of design; the last
evaluator was a doctor doing his residency practice in a rural community.
Once the changes and corrections had been made according to their recommendations, a
more substantial summative evaluation was carried out with ten new evaluators, to identify
usability issues, as well as to carry out tests similar to the reading tests performed on PILs.
Two of these new evaluators had been carers in the past and had administered fentanyl
patches. Not all the evaluators were users of tablet devices. In this way we hoped to capture
both expert opinion and that of less specialised users, both in terms of content and of use of
the content presentation device.
To attempt to simulate real life contexts of use, each evaluation session was carried either in
the home of the tester, or outside in a simulation of a travel situation. The user was given
the tablet with the application.
For each session, the participants were first informed about the application, and it was
emphasised that they were evaluating it, rather than being tested on their aptitude.
Participants were invited to ask questions and then were left to ‘play’ with the application
for a short time. This gave participants who were new to tablets a chance to try out the use
of the device.
The session proceeded as follows: participants filled out a short ‘entry’ questionnaire, then
carried out seven tasks using the tablet and the information presented there, and filled in an
‘exit’ questionnaire. The tasks concerned dosage, application, safe disposal, etc. At the
beginning of each task the participant read out aloud the task description and then began to
search using the tablet, while doing a Concurrent Think Aloud (CTA) protocol, whereby the
participant describes what s/he is doing as s/he does it. This was a valuable exercise, as it
captured qualitative reactions of the evaluators, including their emotional reactions. After
the completion of the tasks and before the exit questionnaire, the participants were asked
to reply to questions about their experience of using the application using a Retrospective
Think Aloud (RTA) protocol. Finally, the exit questionnaire asked participants to comment on
their overall experience of the application in terms of usefulness and usability.

3.7 Evaluation results
The quantitative data from the evaluation were derived from the time taken to complete a
task, combined with the degree of successful completion of the task and the number of
mistakes. The time-based data were used only as an indication, as the participants were also
doing CTA, which would slow them down, but provide useful qualitative results. More
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interestingly, errors were considered as critical or non-critical, depending upon whether the
user could recover from them. Generally speaking, the evaluators were able to complete the
tasks reasonably quickly, and with a low amount of irrecoverable mistakes.
Content

The evaluators felt that the amount of informational content was a good starting point, and
that in future developments, users may want to have access to more information. Some
evaluators commented favourably on the filtering mechanisms (gender and age), employed
in the application, so that only information relevant to the chosen profile was presented,
thereby lessening the cognitive load. This was gratifying as reducing the quantity of
irrelevant information was one of the original aims of the application, since it had surfaced
strongly in the research phase in the online survey.
Operation

There were a number of problems that surfaced, some were trivial to fix, and were a
consequence of the implementation, such as the interactive elements not being clear.
Interestingly this problem was not evident to the inexperienced user, who managed to
complete tasks by using a trial and error method of tapping on everything, rather than
looking for indications of interactivity. However, a more serious consequence of this was
that some evaluators did not realise that by tapping on a sketch, they could activate a box
with explanatory text related to that specific part of the sketch, or that specific sketch in a
series of sketches. Having understood this, they retracted some statements about the need
for more than just pictures to explain the content.
Despite these problems, the evaluators appreciated features like the possibility of scrolling
using the vertical bar to find the information which corresponds to the choice made by a
user. This is another way to reduce user effort in information seeking. This feature in
combination with the horizontal bar, that depicted the seven categories of information,
helped to reduce ‘time to target’ and showed that there was no need to have these in a
central place on the screen, as they can remain in peripheral vision.
Aesthetics

In terms of aesthetics, the participants did not report any particular problem. But they found
that the design was not particularly pleasing. Also, it did not communicate a strong identity
or brand. The latter was the intent of the design team, so that it could either function as an
application interface onto a set of PILs from different manufacturers, or as a template for
manufacturers to adopt with their own online versions of PILs.
Overall

Generalising the results regarding the usefulness of the application, its operation and its
aesthetics, the evaluators found it a useful tool to support rapid and easy information
seeking for medicine usage instructions. They found particularly valuable the notion that
they could access the information at any time and from any device that had the application
running on it. They commented on the use of the QR code to scan in the barcode on the
packaging as being highly valued, as medical names are not easy to spell and many variants
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in terms of different combinations of drugs, as well as drug strengths may exist for one type
of medicine.

Conclusions
This case study looked at a specific medicine classed as a ‘high alert’ medicine. That is, in a
table of fifteen such medicines most commonly reported to have caused serious harm or
death, it ranks seventh in order of magnitude (Barber, 2002).
Our studies showed that there were discrepancies between what patients and medical
professionals perceived as important parts of PILs for Fentanyl products.
Some unexpected results are that this work was carried out using a population that is not
English speaking, and who are not heavily exposed to technological solutions. The internet
penetration in Greece lags behind other countries in Europe and use of internet based
devices is also less widespread. In spite of this, the use of interactive devices to access
information was felt to be more effective than paper-based information.
Participants in the evaluation study expected the application to make more use of the
dynamic information presentation formats. They would have liked to see the use of
multimedia, for instance the application of patches as a video. They felt this would be a very
appropriate way to use even an animation of the existing sketches. It was explained that this
would be quite a departure from the balance of keeping the paper-based leaflet consistent
with the tablet-based information.
The evaluators also suggested a forum for patients to exchange information regarding best
practices and practical tips, as long as such features could be filtered by some authority,
perhaps the manufacturer, and not disorient the user. This finding was consistent with the
new trend in health literacy and information, known as Medicine2.0 or Health 2.0. (Belt et
al., 2010) where users have a say in the quality of content from a collective ‘bottom-up’
approach, which reflects current needs for knowledge and experience sharing in promoting
health literacy.
The main lessons learnt from this experience were that the use of interactive devices to
access patient information is welcomed. Users immediately saw the benefit in having access
to information on their mobile devices rather than relying on a leaflet that gets misplaced,
dirty or damaged. Further, we saw that information presented in this way, while it requires a
restructuring that still recalls the paper information layout, can offer an architecture that is
transparent to the users; allowing them both to navigate and to experience graceful
degrading of information that is irrelevant to them. This irrelevant information is moved into
the periphery, and surfaces more prominently relevant information. Thus, it allows direct
access to desired information, and obviates having to navigate, albeit via scanning headings,
through a linear based document.
Overwhelmingly, our case study showed that there is a need for more information and
guidelines, including good practice, with regard to the information design of ‘instructions for
use’ on mobile media. Having ‘just-in-time’ access to such information can be a powerful

2322

Informing the design of mobile device-based patient instructions leaflets: the case of Fentanyl patches

tool, if it can be used comfortably and quickly by those in need. Such media offer
opportunities for embedding videos, for multi-tasking in the sense of listening to instructions
whilst actually carrying them out, and other, as yet, mostly unused potential. Our results
show that patients and carers are ready for such renderings. Swiping through ‘pages’ of
‘brochureware’ is no longer an acceptable experience for users, however neither is badly
designed web based information that is scattered over many screens with embedded videos
and other features, where users may be swiping through in a haphazard way in the hope of
landing on something useful or required.
We believe the lessons learned from this study are interesting to information designers
involved in designing general ‘Instructions for Use’, as well as to further information design
research in this highly critical area. The intention is not to replace PILs, but to add value to
them by transposing the paper-based document into new delivery channels. This gives to
information design the opportunity to provide some principled responses to the question of
what information should ‘float to the top’ and allows for a new information to be fed back
into mandated paper templates.
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